Rheumatology

Hematologic Malignancies   

Questions discussed in this category


What is your most and least preferred? In case of cancer in remission and in case of non-remission?

There was a recall on viscous lidocaine and many of our patients cannot find it. What would you recommend as alternatives?

Patient was previously well controlled on methotrexate, which was discontinued during cancer treatment.


Papers discussed in this category


JAMA network open, 2018-11-02

The journal of allergy and clinical immunology. In practice, 2017

Rheumatology (Oxford),

Rheumatology (Oxford), 2019 Mar 05

Chest, 2021 Feb

J Am Dent Assoc, 2016 Jan 05

The ocular surface, 2015 Jan 15

Arthritis care & research, 2018-10

Am J Med,

Lupus, 2019 Jun 19

Ann Rheum Dis, 2011 Nov 09

Pediatr Blood Cancer, 2021 Oct

JAMA, 2019 Apr 16

Head Neck, 2016 Mar 29

The Lancet. Oncology, 2017-05

Journal of the Endocrine Society, 2022 Dec 02

Diagnostics (Basel, Switzerland), 2021 Apr 20

Arthritis Care Res (Hoboken), 2021 Jul